Literature DB >> 15001682

PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography.

Thomas H Schindler1, Egbert U Nitzsche, Manfred Olschewski, Ingo Brink, Michael Mix, John Prior, Alvaro Facta, Massayuki Inubushi, Hanjoerg Just, Heinrich R Schelbert.   

Abstract

UNLABELLED: The aims of this study were to determine whether responses in myocardial blood flow (MBF) to the cold pressor testing (CPT) method noninvasively with PET correlate with an established and validated index of flow-dependent coronary vasomotion on quantitative angiography.
METHODS: Fifty-six patients (57 +/- 6 y; 16 with hypertension, 10 with hypercholesterolemia, 8 smokers, and 22 without coronary risk factors) with normal coronary angiograms were studied. Biplanar end-diastolic images of a selected proximal segment of the left anterior descending artery (LAD) (n = 27) or left circumflex artery (LCx) (n = 29) were evaluated with quantitative coronary angiography in order to determine the CPT-induced changes of epicardial luminal area (LA, mm(2)). Within 20 d of coronary angiography, MBF in the LAD, LCx, and right coronary artery territory was measured with (13)N-ammonia and PET at baseline and during CPT.
RESULTS: CPT induced on both study days comparable percent changes in the rate x pressure product (%DeltaRPP, 37% +/- 13% and 40% +/- 17%; P = not significant [NS]). For the entire study group, the epicardial LA decreased from 5.07 +/- 1.02 to 4.88 +/- 1.04 mm(2) (DeltaLA, -0.20 +/- 0.89 mm(2)) or by -2.19% +/- 17%, while MBF in the corresponding epicardial vessel segment increased from 0.76 +/- 0.16 to 1.03 +/- 0.33 mL x min(-1) x g(-1) (DeltaMBF, 0.27 +/- 0.25 mL x min(-1) x g(-1)) or 36% +/- 31% (P <or= 0.0001). However, in normal controls without coronary risk factors (n = 22), the epicardial LA increased from 5.01 +/- 1.07 to 5.88 +/- 0.89 mm(2) (19.06% +/- 8.9%) and MBF increased from 0.77 +/- 0.16 to 1.34 +/- 0.34 mL x min(-1) x g(-1) (74.08% +/- 23.5%) during CPT, whereas patients with coronary risk factors (n = 34) revealed a decrease of epicardial LA from 5.13 +/- 1.48 to 4.24 +/- 1.12 mm(2) (-15.94% +/- 12.2%) and a diminished MBF increase (from 0.76 +/- 0.20 to 0.83 +/- 0.25 mL x min(-1) x g(-1) or 10.91% +/- 19.8%) as compared with controls (P < 0.0001, respectively), despite comparable changes in the RPP (P = NS). In addition, there was a significant correlation (r = 0.87; P <or= 0.0001) between CPT-related percent changes in LA on quantitative angiography and in MBF as measured with PET.
CONCLUSION: The observed close correlation between an angiographically established parameter of flow-dependent and, most likely, endothelium-mediated coronary vasomotion and PET-measured MBF further supports the validity and value of MBF responses to CPT as a noninvasively available index of coronary circulatory function.

Entities:  

Mesh:

Year:  2004        PMID: 15001682     DOI: 10.1097/00006231-200404000-00092

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  Assessment of endothelial function and myocardial flow reserve using (15)O-water PET without attenuation correction.

Authors:  Stéphane Tuffier; Damien Legallois; Annette Belin; Michael Joubert; Alban Bailliez; Michel Redonnet; Denis Agostini; Alain Manrique
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-18       Impact factor: 9.236

2.  Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.

Authors:  T H Schindler; A D Facta; J O Prior; J Cadenas; W A Hsueh; M J Quinones; H R Schelbert
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

3.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

4.  PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.

Authors:  Thomas H Schindler; Alvaro D Facta; John O Prior; Roxana Campisi; Masayuki Inubushi; Michael C Kreissl; Xiao-Li Zhang; James Sayre; Magnus Dahlbom; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-26       Impact factor: 9.236

Review 5.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

6.  Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; Rene Nkoulou; Hanjoerg Just; Osman Ratib; Francois Mach; Magnus Dahlbom; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

Review 7.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 8.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 9.  The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Heinrich R Schelbert; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

10.  Endothelial dysfunction in recently diagnosed type 2 diabetic patients evaluated by PET.

Authors:  Erick Alexanderson; Mónica Rodriguez-Valero; Alfonso Martinez; Rodrigo Calleja; Pedro A Lamothe; Carlos Sierra; Leonardo Garcia-Rojas; Jose Antonio Talayero; Patricio Cruz; Aloha Meave; Graciela Alexanderson
Journal:  Mol Imaging Biol       Date:  2008-09-03       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.